As of May 2024 Prestige Consumer Healthcare has a market cap of $3.47 Billion. This makes Prestige Consumer Healthcare the world's 3224th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $3.47 B | 14.41% |
2023 | $3.03 B | -2.02% |
2022 | $3.10 B | 2.02% |
2021 | $3.03 B | 73.93% |
2020 | $1.74 B | -14.16% |
2019 | $2.03 B | 27.24% |
2018 | $1.59 B | -32.09% |
2017 | $2.35 B | -14.59% |
2016 | $2.75 B | 1.55% |
2015 | $2.71 B | 49.69% |
2014 | $1.81 B | -2.11% |
2013 | $1.85 B | 81.35% |
2012 | $1.02 B | 79.8% |
2011 | $0.56 B | -5.03% |
2010 | $0.59 B | 52.19% |
2009 | $0.39 B | -25.54% |
2008 | $0.52 B | 41.2% |
2007 | $0.37 B | -42.55% |
2006 | $0.65 B | 4.05% |
2005 | $0.62 B |
On May 4th, 2024 the market cap of Prestige Consumer Healthcare was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $359.24 B | 10,236.65% | ๐บ๐ธ USA |
Procter & Gamble PG | $388.14 B | 11,068.30% | ๐บ๐ธ USA |
Novartis NVS | $198.47 B | 5,610.65% | ๐จ๐ญ Switzerland |
Pfizer PFE | $157.47 B | 4,431.07% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $183.75 B | 5,187.24% | ๐บ๐ธ USA |
Clorox CLX | $17.16 B | 393.94% | ๐บ๐ธ USA |
CVS Health CVS | $70.17 B | 1,919.17% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $88.69 B | 2,452.10% | ๐ฌ๐ง UK |
Rite Aid
RAD | $36.75 M | -98.94% | ๐บ๐ธ USA |
Taro Pharmaceutical TARO | $1.59 B | -54.09% | ๐ฎ๐ฑ Israel |